Hyperactivity in children: Is there a treatment of choice?
β Scribed by R. O. Pihl
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 666 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0033-3085
No coin nor oath required. For personal study only.
β¦ Synopsis
Recent studies of treatment procedures for hyperactivity, with special focus on methylphenidate treatment, are reviewed from the perspective of three central questions: What is the effect of the treatment? What is the cost of the treatment? Why does the treatment work? The problems in answering the questions satisfactorily are presented.
"Hyperactivity" is a label applied to school-age children with great frequency. Depending upon the particular survey one reads, this label is affixed to between 4 and 20% of school age children (
π SIMILAR VOLUMES
Acute liver failure (ALF) in children is an uncommon but devastating medical condition. Specific therapy is not available except for a handful of etiologies, such as ALF due to hereditary tyrosinemia or acetaminophen (APAP) overdose.
## Abstract ## BACKGROUND Treatment recommendations for localized prostate carcinoma are based on the patient's remaining life expectancy (RLE), which is influenced by age, comorbidity, and tumor grade. Previous studies have evaluated the influence of age and comorbidity, but to the authors' knowl
## Abstract The present study assessed 89 children in a shortβterm longitudinal study from Junior Kindergarten (age 4β5 years) through Grade 1 (age 6β7 years) using a variety of tests of emergent literacy. Children were assessed for reading skill (a composite of word recognition, decoding, and lett
## Abstract We have examined red blood cell (RBC) thiopurine methyltransferase (TPMT) activity in a healthy population sample of Norwegian children, age 1β10 years. Boys had mean RBC TPMT activity of 11.1 Β± 2.0 U (n = 87) vs. 10.6 Β± 2.2 U (n = 71) in girls, the difference was not significant (__P__